|
|
LiT4 |
|
Vaxjo ID |
168 |
|
Vaccine Adjuvant Name |
LiT4 |
|
Adjuvant VO ID |
VO_0005287
|
|
Description |
tlr4 agonist plus potential inflammasome that induces a mixed Th1/Th2 response |
|
Stage of Development |
Research |
|
Location Licensed |
US (PAI Life sciences Seattle, WA) |
|
Host Species for Testing |
3 |
|
Components |
TLR4 agonist + QS21 |
|
Storage |
2-8C |
| References |
(Carter, 2025): Vaccine Adjuvant Compendium - VAC [https://vac.niaid.nih.gov/view?id=20]
|
|
